Standout Papers

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor 2020 2026 2022 202412.8k
  1. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (2020)
    Markus Hoffmann, Hannah Kleine‐Weber et al. Cell

Immediate Impact

7 by Nobel laureates 21 from Science/Nature 50 standout
Sub-graph 1 of 22

Citing Papers

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
2024 Standout
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
2023 Standout

Works of Simon Schroeder being referenced

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout

Author Peers

Author Last Decade Papers Cites
Simon Schroeder 9701 581 1023 3092 2311 8 13.0k
Hannah Kleine‐Weber 11159 820 1173 3306 2689 11 14.7k
Nadine Krüger 11353 767 1232 3252 2712 40 14.9k
Tanja Herrler 9577 553 1120 3206 3407 40 15.7k
Yushun Wan 6691 754 690 1362 2179 28 8.9k
Tobias S. Schiergens 9608 563 1202 3085 2481 79 14.0k
Yi Hu 6486 543 746 1802 1758 43 9.5k
Jian Shang 7260 1026 678 1405 2032 56 9.3k
Alexandra C. Walls 9238 1554 874 991 3678 32 11.5k
Fengyun Gong 9061 90 1273 4102 993 21 13.7k
Yang Han 9542 155 1303 4196 1165 51 14.3k

All Works

Loading papers...

Rankless by CCL
2026